Botulinum toxin A treatment of the lower extremities in children with cerebral palsy

Journal of Children's Orthopaedics

Volumn 7, Issue 5, 2013, Pages 383-387

  Molenaers, Guy ^a,b   Fagard, Katrien ^c   Van Campenhout, Anja ^a,b   Desloovere, Kaat ^b,c  

^a UZ Pellenberg ^*  (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

BTX A; Cerebral palsy; Gait analysis; Goal attainment scale; Long term effect

Indexed keywords

EID: 84888359134     PISSN: 18632521     EISSN: 18632548     Source Type: Journal    
DOI: 10.1007/s11832-013-0511-x     Document Type: Review

References (17)

1. Aoki KR (2003) Pharmacology and immunology of botulinum toxin type A. Clin Dermatol 21: 476-480.
2. Aoki KR, Ranoux D, Wissel J (2006) Using translational medicine to understand clinical differences between botulinum toxin formulations. Eur J Neurol 13: 10-19.
3. Schroeder AS, Ertl-Wagner B, Britsch S, Schröder JM, Nikolin S, Weis J, Müller-Felber W, Koerte I, Stehr M, Berweck S, Borggraefe I, Heinen F (2009) Muscle biopsy substantiates long-term MRI alterations one year after a single dose of botulinum toxin injected into the lateral gastrocnemius muscle of healthy volunteers. Mov Disord 24(10): 1494-1503.
4. Cans C (2000) Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Dev Med Child Neurol 42: 816-824.
5. Reid SM, Carlin JB, Reddihough DS (2010) Distribution of motor types in cerebral palsy: how do registry data compare? Dev Med Child Neurol 53(3): 233-238.
6. Molenaers G, van Campenhout A, Fagard K, De Cat J, Desloovere K (2010) The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limb. J Child Orthop 4(3): 183-195.
7. Lee J, Sung I, Yoo J, Park E, Park S (2009) Effects of different dilutions of botulinum toxin type A treatment for children with cerebral palsy with spastic ankle plantar flexor: a randomized control trial. J Rehab Med 41: 740-745.
8. Lukban M, Rosales R, Dressler D (2009) Effectiveness of botulinum toxin A for upper and lower limb spasticity children with cerebral palsy: a summary of evidence. J Neural Transm 116: 319-331.
9. Bjornson K, Hays R, Graubert C, Price R, Won F, McLaughlin JF, Cohen M (2007) Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation. Pediatrics 120(1): 49-58.
10. Desloovere K, Molenaers G, De Cat J, Pauwels P, van Campenhout A, Ortibus E, Fabry G, De Cock P (2007) Motor function following multilevel botulinum toxin type A treatment in children with cerebral palsy. Dev Med Child Neurol 49(1): 56-61.
11. Scholtes V, Dallmeijer A, Knol D, Speth LA, Maathuis CG, Jongerius PH, Becher JG (2007) Effect of multilevel botulinum toxin A and comprehensive rehabilitation on gait in cerebral palsy. Pediatr Neurol 36(1): 30-39.
12. Desloovere K, Molenaers G, Feys H, Huenaerts C, Callewaert B, van de Walle P (2006) Do dynamic and static clinical measurements correlate with gait analysis parameters in children with cerebral palsy? Gait Posture 24(3): 302-13.
13. Heinen F, Desloovere K, Schroeder AS, Berweck S, Borggraefe I, van Campenhout A, Andersen GL, Aydin R, Becher JG, Bernert G, Caballero IM, Carr L, Valayer EC, Desiato MT, Fairhurst C, Filipetti P, Hassink RI, Hustedt U, Jozwiak M, Kocer SI, Kolanowski E, Krägeloh-Mann I, Kutlay S, Mäenpää H, Mall V, McArthur P, Morel E, Papavassiliou A, PascualPascual I, Pedersen SA, Plasschaert FS, van der Ploeg I, Remy-Neris O, Renders A, Di Rosa G, Steinlin M, Tedroff K, Valls JV, Viehweger E, Molenaers G (2010) The updated European Consensus 2009 on the use of botulinum toxin for children with cerebral palsy. Eur J Paediatr Neurol 14: 45-66.
14. Childers MK (1997) Rationale for localized injection of botulinum toxin type A in spasticity. Eur J Neurol 4: S37-S40.
15. Childers M (2004) Targeting the neuromuscular junction in skeletal muscles. Am J Phys Med Rehabil 83: S38-S44.
16. van Campenhout A, Molenaers G (2010) Localization of the motor endplate zone in human skeletal muscles of the lower limb: anatomical guidelines for injection with botulinum toxin. Dev Med Child Neurol 53(2): 108-119.
17. Desloovere K, Schörkhuber V, Fagard K, van Campenhout A, De Cat J, Pauwels P, Ortibus E, De Cock P, Molenaers G (2012) Botulinum toxin type A treatment in children with cerebral palsy: evaluation of treatment success or failure by means of goal attainment scaling. Eur J Paediatr Neurol 16(3): 229-236.